[What's new in pericardial disease?] / Was ist neu bei Perikard-Erkrankungen?
Dtsch Med Wochenschr
; 147(11): 704-710, 2022 06.
Article
in German
| MEDLINE | ID: covidwho-1873574
ABSTRACT
Pericardial disease represents a large diversity of inflammation related injury of the pericardium. Multifactorial causes may contribute to acute and recurrent pericarditis, pericardial effusion without major hemodynamic compromise, cardiac tamponade or constrictive pericarditis. Currently, inflammatory pericardial pathologies are observed in cases of SARS-CoV-2-infection or after vaccination. Beside established anti-inflammatory therapeutic strategies with NSAID, corticosteroids and colchicine, auto-inflammation and inflammasomes seam to offer more specific targets for advanced treatment options.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pericardial Effusion
/
Cardiac Tamponade
/
COVID-19
Type of study:
Diagnostic study
Topics:
Long Covid
/
Vaccines
Limits:
Humans
Language:
German
Journal:
Dtsch Med Wochenschr
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS